Production (Stage)
NRx Pharmaceuticals, Inc.
NRXP
$3.27
$0.3311.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.51M | -9.08M | -1.62M | -7.90M | -6.53M |
| Total Depreciation and Amortization | -- | 1.00K | 2.00K | 1.00K | 1.00K |
| Total Amortization of Deferred Charges | 350.00K | 896.00K | -- | -- | -- |
| Total Other Non-Cash Items | 1.68M | 13.23M | -728.00K | 2.29M | 569.00K |
| Change in Net Operating Assets | 0.00 | -86.00K | 43.00K | 3.05M | 2.29M |
| Cash from Operations | -3.48M | -2.10M | -2.31M | -2.56M | -3.67M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5.00M | 4.14M | 2.94M | -- | -- |
| Total Debt Repaid | -320.00K | -3.78M | -2.64M | -1.00K | -2.16M |
| Issuance of Common Stock | 3.26M | 0.00 | 219.00K | 3.14M | 2.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -350.00K | 1.53M | 1.54M | -- | -- |
| Cash from Financing | 7.59M | 1.90M | 2.05M | 3.14M | 395.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.11M | -203.00K | -252.00K | 579.00K | -3.28M |